Multi-Center Randomized Controlled Phase 2b Clinical Trial To Evaluate The Safety And Efficacy Of Tvi-Brain-1 Combined With Conformal Radiotherapy And Temozolomide Compared To Standard Therapy As A Treatment For Newly Diagnosed O6 -Methylguanine Methyltransferase Negative MGMT Unmethylated Grade 4 Astrocytoma Glioblastoma Multiforme; GBM

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05685004

Study #:
STUDY00150136

Start Date:
Nov 28, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05685004

View Complete Trial Details & Eligibility at ClinicalTrials.gov